JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

JNJ

230.64

+1.43%↑

ISRG

496

-1.52%↓

ABT

109.39

+0.15%↑

RDY

13.59

+1.42%↑

NEOG

10.23

+0.2%↑

Search

Teleflex Inc

Geschlossen

BrancheGesundheitswesen

103.3 -0.97

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

102.59

Max

104.31

Schlüsselkennzahlen

By Trading Economics

Einkommen

-531M

-409M

Verkäufe

132M

913M

KGV

Branchendurchschnitt

28.636

90.422

Dividendenrendite

1.32

Gewinnspanne

-44.785

Angestellte

14,100

EBITDA

-546M

-323M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+24.72% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.32%

2.13%

Nächstes Ergebnis

26. Feb. 2026

Nächste Dividendenausschüttung

16. März 2026

Nächstes Ex-Dividendendatum

6. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-824M

4.6B

Vorheriger Eröffnungskurs

104.27

Vorheriger Schlusskurs

103.3

Nachrichtenstimmung

By Acuity

50%

50%

147 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Teleflex Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Feb. 2026, 23:52 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott Management Doesn't Plan to Tender Its Shares at the Current Terms

2. Feb. 2026, 23:52 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott Management: Toyota Fudosan Revised Tender Offer for Toyota Industries 'Very Significantly Undervalues' Company

2. Feb. 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

2. Feb. 2026, 23:38 UTC

Market Talk

Gold Rises on Likely Technical Recovery, Dip-Buying Interest -- Market Talk

2. Feb. 2026, 23:28 UTC

Market Talk

SpaceX, xAI Deal Further Consolidates Musk's Businesses -- Market Talk

2. Feb. 2026, 23:23 UTC

Ergebnisse

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- 2nd Update

2. Feb. 2026, 22:57 UTC

Ergebnisse

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2. Feb. 2026, 22:22 UTC

Akquisitionen, Fusionen, Übernahmen

What the Blockbuster SpaceX--xAI Merger Can Mean for Tesla Stock -- Barrons.com

2. Feb. 2026, 22:08 UTC

Market Talk

Australian Inflation Woes Rooted In Excess Govt Spending -- Market Talk

2. Feb. 2026, 21:51 UTC

Ergebnisse

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2. Feb. 2026, 21:49 UTC

Ergebnisse

Disney's Streaming Profit Surges as CEO Decision Approaches -- 5th Update

2. Feb. 2026, 21:39 UTC

Ergebnisse

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2. Feb. 2026, 21:36 UTC

Ergebnisse

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- Update

2. Feb. 2026, 21:34 UTC

Ergebnisse

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2. Feb. 2026, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

What a SpaceX--xAI Merger Could Mean for Tesla Stock -- Barrons.com

2. Feb. 2026, 21:23 UTC

Ergebnisse

BYD, Chinese EV Stock Plunge On Weak Data. What That Means for Tesla Stock. -- Barrons.com

2. Feb. 2026, 21:19 UTC

Ergebnisse

Palantir Technologies: U.S. Commercial Business Growing at 'Astonishing' Rate, Generating $507 Million Last Quarter, 137% Increase Over the Same Period the Year Before >PLTR

2. Feb. 2026, 21:17 UTC

Ergebnisse

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- WSJ

2. Feb. 2026, 21:17 UTC

Ergebnisse

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2. Feb. 2026, 21:10 UTC

Ergebnisse

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2. Feb. 2026, 21:08 UTC

Ergebnisse

Palantir Technologies: Rule of 40 Score Is Now 127% >PLTR

2. Feb. 2026, 21:07 UTC

Ergebnisse

Palantir Technologies: Sees 2026 U.S. Comml Rev in Excess of $3.144B, Representing Growth Rate of at Least 115% >PLTR

2. Feb. 2026, 21:05 UTC

Ergebnisse

Palantir Technologies 4Q Net $608.7M >PLTR

2. Feb. 2026, 21:05 UTC

Ergebnisse

Palantir Technologies 4Q Rev $1.41B >PLTR

2. Feb. 2026, 21:05 UTC

Ergebnisse

Palantir Technologies Sees 1Q Rev $1.53B-$1.54B >PLTR

2. Feb. 2026, 21:05 UTC

Ergebnisse

Palantir Technologies Sees FY Rev $7.18B-$7.2B >PLTR

2. Feb. 2026, 21:05 UTC

Ergebnisse

Palantir Technologies 4Q Adj EPS 25c >PLTR

2. Feb. 2026, 21:05 UTC

Ergebnisse

Palantir Technologies 4Q EPS 24c >PLTR

2. Feb. 2026, 20:40 UTC

Market Talk

Treasury Yields, Dollar Rise Amid Signs of Resilient U.S. Economy -- Market Talk

Peer-Vergleich

Kursveränderung

Teleflex Inc Prognose

Kursziel

By TipRanks

24.72% Vorteil

12-Monats-Prognose

Durchschnitt 130.17 USD  24.72%

Hoch 155 USD

Tief 115 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Teleflex Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

7 ratings

2

Buy

4

Halten

1

Sell

Technischer Score

By Trading Central

122.73 / 135.75Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

No Evidence

Stimmung

By Acuity

147 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Teleflex Inc

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
help-icon Live chat